Let’s get this part out of the way first: Trail cameras are a pain. Batteries die, SD cards get corrupted, settings get messed up, and squirrels trigger thousands of useless images. So why would you ...

Swiss IoT module maker u-blox is to phase out its loss-making cellular IoT business, the firm has said. The division has over 200 employees; jobs are expected to go with its closure. It made revenue ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The best phone carrier delivers reliable service at an affordable cost while responding ...

I'm not sure how many of you know today what Nokia once used to mean for all of us: the Finnish-born telecom company was way back at the forefront of the mobile phone revolution, dwarfing all ...

The Netherlands is solidifying its status as a global leader in sustainable food innovation with significant investments to advance its protein transition. Two new “pioneering” open-access scale-up ...

If it weren’t for hunting blinds, I might not have killed my first deer as a kid. I was barely a teen, and had just started hunting on my own. I was anything but stealthy. My dad made the wise ...

It looks like T-Mobile is now accepting customers into the free beta program for SpaceX’s cellular Starlink service—but only if you have the latest Samsung handsets. On Tuesday, a number of T ...

A new year is the perfect time to make sure you've got the best cell phone plan for your needs — and if you don't, it's time to consider your options for getting more data at a lower monthly cost.

Copyright 2025 The Associated Press. All Rights Reserved. The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024. (AP Photo/Ted Shaffrey ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said. A ...